Roles of Epigenetics in Cardiac Fibroblast Activation and Fibrosis

Area of Science:

• Cardiovascular Biology
• Epigenetics
• Fibrosis Research

Background:

• Cardiac fibrosis, a hallmark of cardiovascular diseases, involves cardiac fibroblast (CF) activation and excessive extracellular matrix production.
• CFs transition from a quiescent state to activated myofibroblasts under pathological stress, driving fibrosis.
• Epigenetic regulation is increasingly recognized as a key mediator linking pathological stimuli to CF activation and cardiac fibrosis.

Purpose of the Study:

• To review recent advances in understanding epigenetic regulation in cardiac fibrosis.
• To highlight the impact of epigenetic modifications on cardiac fibroblast activation.
• To discuss future perspectives for epigenetic research in cardiac fibrosis.

Main Methods:

• Literature review of recent studies on epigenetics and cardiac fibrosis.
• Analysis of epigenetic mechanisms (DNA methylation, histone modifications, non-coding RNAs) in CF activation.
• Synthesis of current knowledge on the role of epigenetics in cardiac fibrosis pathogenesis.

Main Results:

• Epigenetic modifications significantly influence cardiac fibroblast activation and extracellular matrix production.
• DNA methylation, histone modifications, and non-coding RNAs are key epigenetic players in cardiac fibrosis.
• These epigenetic changes provide a link between environmental/pathological stress and cardiac dysfunction.

Conclusions:

• Epigenetic regulation is a critical determinant of cardiac fibrosis.
• Targeting epigenetic modifications in cardiac fibroblasts presents a promising therapeutic strategy for cardiovascular diseases.
• Further research into epigenetic mechanisms is essential for developing novel treatments for cardiac fibrosis.